ÆäÀÌÁö ÇöÀç À§Ä¡
HOME > ¿¬±¸ºÎ¼ > ¹ÙÀÌ¿ÀÀǰúÇבּ¸ºÎ > ¹ÙÀÌ¿À½Å¾àÁß°³¿¬±¸¼¾ÅÍ
¹ÙÀÌ¿À½Å¾àÁß°³¿¬±¸¼¾ÅÍ
¹ÙÀÌ¿À½Å¾àÁß°³¿¬±¸¼¾ÅÍ

³Ä¡Áúȯ Ç¥ÀûÄ¡·á¸¦ À§ÇÑ ¹ÙÀÌ¿À½Å¾à Ç÷§Æû ±â¼ú °³¹ß
- ´Ù±â´É Ç×ü ¶óÀ̺귯¸® ±â¹Ý Ç¥Àû ¹ß±¼ ¹× Á¦¾î ±â¼ú °³¹ß
- À¯ÀüÀÚÄ¡·áÁ¦ °³¹ßÀ» À§ÇÑ À¯ÀüÀÚÁ¦¾î ±â¼ú °³¹ß
¿¬±¸¿ø ¼º¸íÀ» Ŭ¸¯ Çϼ¼¿ä
- ¾Ï/Ç÷°ü½Å»ý/Ç÷°ü¿°Áõ Á¶Àý Ç¥Àû ¹ß±¼ ¹× Á¦¾î ±â¼ú °³¹ß
- ´Ù±â´É Ç×ü ¶óÀ̺귯¸® ½Ã½ºÅÛ ±â¹Ý Ç¥Àû ¹ß±¼ ¹× Ç×ü °³¹ß
- Áٱ⼼Æ÷ ±â¹Ý Ç÷°ü³»ÇǺÐÈÁ¶Àý
- ¾àÁ¦³»¼º ¹× ¾ÏÀüÀÌ Á¶Àý ±Ô¸í ¹× Á¦¾î ±â¼ú °³¹ß
- ±âÃÊ-ÀÓ»ó Áß°³¿¬±¸¸¦ ÅëÇÑ ½Å¾à°³¹ß
- ¾Ï ƯÀÌÀû ¼¼Æ÷´ë»ç-½ÅÈ£¸¦ Ç¥ÀûÀ¸·Î ÇÑ Áúȯ Ä¡·áÁ¦ °³¹ß ¹× Àû¿ë±â¼ú °³¹ß¿¬±¸
- ¾Ï¼¼Æ÷ ´ë»çü Á¥»êÀÇ ¿ªÇÒ ¹× ÀÛ¿ë±âÀü ¿¬±¸
- Á¥»ê ½ÅÈ£Àü´Þü°è Á¶ÀýÀ» ÅëÇÑ Áúȯ Ä¡·á±â¼ú ¿¬±¸
- ¸é¿ª°áÇ̵ÅÁö »ý»ê¿¡ °ü·ÃÇÑ À¯ÀüÀÚ ¹ß±¼
- ¸é¿ª°ÅºÎ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ÀÎÀÚ¿¡ ´ëÇÑ ¸ÞÄ¿´ÏÁò ¿¬±¸
- Áúȯµ¿¹° »ý»ê ¹× ±â´ÉÀû ¿¬±¸
- Gene editing systemÀ» ÀÌ¿ëÇÑ À¯ÀüÀÚ °á¼Õ ¹× º¯ÀÌ µ¿¹° »ý»ê
- µ¿¹°¸ðµ¨À» ÀÌ¿ëÇÑ ºÐÀÚÀ¯ÀüÇÐÀû ¹× »ý¸®ÇÐÀû ±â´É¿¡ ´ëÇÑ ¿¬±¸
- Ç÷°ü½Å»ý Á¶Àý ½Å±Ô ´Ü¹éÁú ¹ß±¼ ¹× ±â´É ±Ô¸íÀ» ÅëÇÑ ¾Ï/Ç÷°üÄ¡·á±â¼ú Á¦°ø
- Ç×ü±â¹Ý Ç÷°ü½Å»ý Ȱ¼º/Á¦¾î ±â¼ú
- Ç÷°ü³»ÇǺÐÈ Á¶Àý Ç÷§Æû ±¸ÃàÀ» ÅëÇÑ ¼¼Æ÷Ä¡·áÁ¦ ±â¼ú
- Ç÷°ü¿°Áõ/Åõ°ú¼º Á¶Àý Å»ÀλêÈÈ¿¼Ò ¹ß±¼ ¹× »õ·Î¿î ¿°ÁõÁ¶Àý ±âÀü ±Ô¸í
- ¼¼Æ÷´ë»çü Á¥»êÀÇ ÁúȯÀ¯¹ß°ü·Ã »õ·Î¿î ±â´É ±Ô¸í
- Áúȯ À¯¹ß Àú»ê¼ÒÁõ ÀÛ¿ëÀÇ »õ·Î¿î ½ÅÈ£±âÀü ¹× »ý¸®ÇÐÀû/º´¸®ÇÐÀû ¿ªÇÒ ±Ô¸í
- ¾Ï ƯÀÌÀû ´ë»ç»ê¹°ÀÎ Á¥»êÀÇ ±â´ÉÀ» Á¶ÀýÇÏ´Â ÁÖ¿äÀÎÀÚ ¹ß°ß
- ¾àÁ¦³»¼º ¹× ¾ÏÀüÀÌ Á¶ÀýÀÎÀÚ ±Ô¸í°ú Á¦¾î ±â¼ú °³¹ß ¹× ±âÃÊ-ÀÓ»ó Áß°³¿¬±¸ ±¸Ãà
- µÅÁö T-cell, B-cell ¸é¿ª°áÇÌ ¼¼Æ÷ÁÖ »ý»ê
- ÀÌÁ¾Àå±â ÀÌ½Ä¿ë ¹Ì´Ï º¹Á¦µÅÁö »ý»ê À§ÇÑ À¯ÀüÀÚ Á¶ÀÛµÈ ¼¼Æ÷ÁÖ È®¸³

- Jeong-Ki Min (corresponding) J. Hepatology. 63:1429-1439.
- Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
- Jang Seong Kim (first) Jeong-Ki Min (corresponding) Biomaterials 51:119-28
- Stimulation of angiogenesis and survival of endothelial cells by human monoclonal Tie2 receptor antibody
- Jeong-Ki Min (corresponding) Clin. Cancer Res. 18(12):3270-80
- Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor
- Jeong-Ki Min (first) J. Clin. Invest. 121(5):1882-93
- The WNT antagonist Dickkopf2is a novel promoter of angiogenesis. In rodents and human endothelial cells.
- Dong Chul Lee (first) and Young Il Yeom (corresponding) Cell 161(3):595-609.
- A lactate-induced response to hypoxia.
- Young Il Yeom (corresponding) Exp Cell Res. 336(1):119-29.
- Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells.
- Jang Seong Kim (Co-corresponding) Clin Cancer Res. 19(19):5340-50.
- Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies
- Jeong-Woong Lee (Second) J. Neuroscience, 35(11):4587-5498
- Mutations in the microtubule-associated protein 1A (Map1a) gene cause Purkinje cell degeneration
- Jeong-Woong Lee (Corresponding) Life Science, 132:49-54
- Small heterodimer partner-interacting leucine zipper protein inhibits adipogenesis by regulating peroxisome proliferator-activated receptor ¥ã activity
- Jeong-Woong Lee (Corresponding) Bone, 61:10-8
- SMILE inhibits BMP-2-induced expression of osteocalcin by suppressing the activity of the RUNX2 transcription factor in MC3T3E1 cells